Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Perinatal maternal opioid use: Exploring prescribing trends, and the maternal and neonatal safety of postpartum opioids using administrative data

FY 2018-19

Summary
Opioids, such as codeine, morphine, oxycodone, and fentanyl are drugs used for the treatment of pain. The prescribing of opioids has increased dramatically over the past two decades. While the majority of opioid prescriptions are well intentioned, they are often prescribed in larger quantities, for far longer than intended, which has led to the genesis and propagation of the opioid epidemic. One area of this epidemic that has been less well explored is the prescription of opioids to women following childbirth. Over 15,000 Ontario women a year are newly started on opioids following the birth of a child. My doctoral thesis will use large healthcare databases to examine the maternal and child health consequences associated with the prescription of opioids to mothers following childbirth. We plan to conduct three interrelated studies that focus around this central theme. The first study will examine trends in opioid prescribing to women after birth of a child in Ontario. A high profile case report published in 2006 described the potential harm of codeine use during breastfeeding. This report may have led to an overall decrease in codeine use, and an increase in oxycodone use among new mothers. This is of concern because oxycodone is a far stronger opioid drug with a greater potential for long-term abuse and dependence. The second study will examine whether oxycodone use is a risk factor for persistent maternal opioid use following childbirth. We believe there is a greater risk of long-term opioid use in mothers prescribed oxycodone, compared to codeine. The final study will examine the risks to babies associated with maternal opioid use following childbirth. Many clinicians believe that breastfeeding newborns are at risk of harm from opioids ingested via breast milk. We will assess whether there is an increased risk of harm in newborns whose mothers received an opioid prescription relative to those whose mothers did not.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406746
Name
Zipursky Jonathan S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Perinatal maternal opioid use: Exploring prescribing trends, and the maternal and neonatal safety of postpartum opioids using administrative data
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Breastfeeding; Maternal And Fetal Outcomes; Opioids; Perinatal Drug Safety; Pregnancy
Abstract
Opioids, such as codeine, morphine, oxycodone, and fentanyl are drugs used for the treatment of pain. The prescribing of opioids has increased dramatically over the past two decades. While the majority of opioid prescriptions are well intentioned, they are often prescribed in larger quantities, for far longer than intended, which has led to the genesis and propagation of the opioid epidemic. One area of this epidemic that has been less well explored is the prescription of opioids to women following childbirth. Over 15,000 Ontario women a year are newly started on opioids following the birth of a child. My doctoral thesis will use large healthcare databases to examine the maternal and child health consequences associated with the prescription of opioids to mothers following childbirth. We plan to conduct three interrelated studies that focus around this central theme. The first study will examine trends in opioid prescribing to women after birth of a child in Ontario. A high profile case report published in 2006 described the potential harm of codeine use during breastfeeding. This report may have led to an overall decrease in codeine use, and an increase in oxycodone use among new mothers. This is of concern because oxycodone is a far stronger opioid drug with a greater potential for long-term abuse and dependence. The second study will examine whether oxycodone use is a risk factor for persistent maternal opioid use following childbirth. We believe there is a greater risk of long-term opioid use in mothers prescribed oxycodone, compared to codeine. The final study will examine the risks to babies associated with maternal opioid use following childbirth. Many clinicians believe that breastfeeding newborns are at risk of harm from opioids ingested via breast milk. We will assess whether there is an increased risk of harm in newborns whose mothers received an opioid prescription relative to those whose mothers did not.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zipursky, Jonathan S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~